RaDIANT Health Systems Intervention

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorIndiana University

About this trial

The overarching goal of the proposed study is to determine whether the addition of structural interventions at the health system level targeting upstream barriers in the transplant process will improve access to transplant evaluation start.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Five large transplant centers (Emory Transplant Center and Piedmont Transplant Center in Atlanta, GA; Medical University of SC; Duke University in Durham, NC; and Indiana University in Indianapolis, IN) ~800 referring dialysis center referring to these transplant centers

Disqualifiers

Individuals referred, initiating evaluation, and waitlisted at non-participating start centers

Trial design

Design model

Single group

Treatments tested in this trial

  • Performance Feedback Reports on Referral and Evaluation Closures

    Other intervention

    Performance feedback reports will reflect each transplant center's performance related to kidney transplant evaluation initiation and referral closure. These reports aim to help centers understand common reasons why patients do not initiate the evaluation process or failed to proceed beyond the evaluation process, and to identify patterns in referral and evaluation closure practices. Reports will be individualized and distributed quarterly to the transplant center champion by the intervention lead.

  • Dialysis Facility Awareness Campaign

    Other intervention

    As part of the intervention, dialysis centers will participate in an Awareness Campaign designed to educate staff about transplant center quality improvement efforts and how they may be contacted as part of the project. This campaign may include brief webinars or informative documents distributed via platforms such as IPRO Learn.

  • Patient Contact via Preferred Method

    Other intervention

    Transplant centers will contact patients using their preferred method of communication.

  • Phone Call to Dialysis Facility During the Patient's Dialysis Session

    Other intervention

    Facilities will enhance their patient communication procedures by making a phone call to the dialysis facility during the patient's dialysis session if the patient has not responded to initial outreach attempts. This additional step increases the likelihood of reaching the patient during a time when they are accessible and can engage in scheduling or follow-up.

  • Phone Call to Provider

    Other intervention

    Transplant centers will enhance their outreach procedures by making a phone call to the referring provider (e.g., nephrologist, medical assistant) or another provider involved in the patient's care (e.g., primary care provider) in the event of self-referral if the patient has not responded to initial outreach attempts or "no-shows" an initial evaluation appointment. This additional step ensures that the referring provider is informed of the patient's progress and can assist in re-engagement or decision-making prior to referral closure.

  • Transplant Referral Communication Platforms or Email to Communicate Patient Status and No-Show

    Other intervention

    Transplant center staff will utilize transplant referral communication platforms and/or email to communicate updates to dialysis staff regarding patient status (e.g., unable to contact the patient or no-show) before referral closure.

  • Audit and Tracking of Patient Contact Attempts Prior to Referral Closure

    Other intervention

    Transplant center staff will continue internally tracking the frequency that a patient is contacted before closure and the date of closure, in alignment with center standard practice. This intervention introduces an audit process to be conducted before closure to ensure that all contact attempts (including one or more attempts to contact the patient directly, one or more phone calls to the alternate preferred contact, or one or more attempted contacts to the dialysis unit to connect with the patient), in alignment with center communication procedures, are appropriately executed.

Treatment groups

14,000 Participants
are divided into 1 treatment group
Group A: Multi-Component InterventionExperimental treatment 7 interventions

Trial outcomes

Primary outcomes

1

Change in transplant evaluation start within 6 months of transplant referral

The difference in the proportion of patients starting transplant evaluation within 6 months of being referred from baseline to up to one-year post-intervention

Time frame
Baseline, Post Intervention (Up to one year)

Secondary outcomes

1

Change in transplant waitlisting

The difference in the proportion of patients waitlisted from baseline and up to one-year post-intervention

Time frame
Baseline, Post Intervention (Up to one year)
2

Change in transplant receipt among those who were waitlisted

The difference in the proportion of patients who received a transplant among those who were waitlisted from baseline and up to one-year post-intervention

Time frame
Baseline, Post Intervention (Up to one year)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Indiana University

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Indiana University Health

Collaborator

Emory Healthcare

Collaborator

Piedmont Healthcare

Collaborator

Medical University of South Carolina

Collaborator

Duke University

Collaborator